companyprofile

Actions

Mouwasat Medical Services Co.

4002
MOUWASAT
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Main Market
  • Health Care Equipment & Svc

Stats Overview

  • Prev. Close 121.60
  • Open 122.60
  • High 125.40
  • Low 122.00
  • No. of Trades 1,798
  • Avg. Trade size* 90
  • Volume Traded 162,280
  • Value Traded (SAR) 20,150,435.00

Performance

MOUWASAT
3.20 ( 2.63% )
Compare
Name Price Change %
Mouwasat Medical Services Co. 122.60 2.63%
Note: Prices are delayed minimum 5 minutes
  • *Average Trade Size = Cumulative / # of Trades
  • **52 Week Price Change =   (Current Price - Price year ago) / Price year ago x 100
  • Historical prices & volume traded data are adjusted to account for all corporate actions.
  • MO: Market Order

Trade Updates

Last Trade

Price
124.80
% Change
2.63
Volume Traded
2

Best Bid

Price 124.40
Volume 8,638

Best Offer

Price 124.80
Volume 9,504

52 WEEK

High
144.00
2024/04/16
Low
92.50
2023/10/24
Change**
3.14

PERFORMANCE

Start of Year
114.8
Year ago
121
3 Years ago
90.5

Compare Selected

Select a Maximum of 5 Companies

Compare Selected

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist

AnnouncmentandCorporateAction

Actions
Jump To :
  • Announcements & Corporate Actions
  • Dividends
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Announcements

  • Mouwasat Medical Services Company announces the establishment of Modawa and Rieaya Medical Company “Ltd” in partnership with Aldawaa Medical Services Co.

    4002
    MOUWASAT 2.63 %
    1445/11/29     06/06/2024 15:56:35
  • Addendum Announcement from Mouwasat Medical Services Co. in regards to results of the ordinary General Assembly Meeting, ( First Meeting )

    4002
    MOUWASAT 2.63 %
    1445/11/20     28/05/2024 16:00:07
  • Mouwasat Medical Services Co. Announces the Results of the Ordinary General Assembly Meeting, ( First Meeting )

    4002
    MOUWASAT 2.63 %
    1445/11/20     28/05/2024 08:00:50
  • Mouwasat Medical Services Co. announces that it has conducted an Earnings Call to discuss the financial results for the first quarter of 2024 with Investors and Financial Analysts.

    4002
    MOUWASAT 2.63 %
    1445/11/13     21/05/2024 15:48:25
  • Mouwasat Medical Services Co. announces its Interim Financial results for the Period Ending on 2024-03-31 ( Three Months )

    4002
    MOUWASAT 2.63 %
    1445/11/05     13/05/2024 16:06:35
View All

Corporate Actions

Upcoming Events

    Past Events

      Jump To :
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Dividends

      Announced Date Eligibility Date Distribution Date Distribution Way Dividend Amount
      25/12/2023 27/05/2024 06/06/2024 Account Transfer 1.75
      22/12/2022 07/05/2023 17/05/2023 Account Transfer 3.00
      17/01/2022 09/05/2022 19/05/2022 Account Transfer 2.75
      25/02/2021 29/04/2021 09/05/2021 Account Transfer 2.50
      16/03/2020 22/04/2020 06/05/2020 Account Transfer 2.00

      CompanyProfilev2Financials

      Actions
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Financials

      • FINANCIAL INFORMATION
      • FINANCIAL STATEMENTS AND REPORTS
      • Annually
      • Quarterly
      Balance Sheet 2023-12-31
      Total Assets
      4,964,547
      - - -
      Total Liabilities
      1,537,700
      - - -
      Total Shareholders Equity (After Deducting the Minority Equity)
      3,277,056
      - - -
      Total Liabilities and Shareholders Equity
      4,964,547
      - - -
      Statement of Income 2023-12-31
      Total Revenue (Sales/Operating)
      2,705,508
      - - -
      Net Profit (Loss) before Zakat and Tax
      696,387
      - - -
      Zakat and Income Tax
      -38,699
      - - -
      Net Profit (Loss) after Zakat and Tax
      657,688
      - - -
      Total Comprehensive Income
      654,210
      - - -
      Profit (Loss) per Share
      3.29
      - - -
      Cash Flow 2023-12-31
      Net Cash From Operating Activities
      813,783
      - - -
      Net Cash From Investing Activities
      -474,702
      - - -
      Net Cash From Financing Activities
      -433,908
      - - -
      Cash and Cash Equivalents, Beginning of the Period
      143,876
      - - -
      Cash and Cash Equivalents, End of the Period
      49,049
      - - -
      All Figures in Thousands
      All Currency In SAR
      Last Update Date 2024-03-25

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Balance Sheet 2024-03-31 2023-09-30
      Total Assets
      5,385,599
      4,927,275
      Total Liabilities
      1,781,899
      1,689,372
      Total Shareholders Equity (After Deducting the Minority Equity)
      3,448,637
      3,096,368
      Total Liabilities and Shareholders Equity
      5,385,599
      4,927,275
      Statement of Income 2024-03-31 2023-09-30
      Total Revenue (Sales/Operating)
      722,784
      640,890
      Net Profit (Loss) before Zakat and Tax
      190,663
      167,509
      Zakat and Income Tax
      -13,810
      -11,134
      Net Profit (Loss) after Zakat and Tax
      171,581
      156,375
      Total Comprehensive Income
      171,581
      156,375
      Profit (Loss) per Share
      0.86
      0.78
      Cash Flow 2024-03-31 2023-09-30
      Net Cash From Operating Activities
      242,689
      667,223
      Net Cash From Investing Activities
      233,568
      -351,333
      Net Cash From Financing Activities
      66,177
      -352,709
      Cash and Cash Equivalents, Beginning of the Period
      49,050
      143,877
      Cash and Cash Equivalents, End of the Period
      124,347
      107,058
      All Figures in Thousands Thousands
      All Currency In SAR SAR
      Last Update Date 2024-05-15 2023-11-02

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Display Previous Periods
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Shareholding Information

      • Board Of Directors
      • Foreign Ownership
      • Substantial Shareholders
      Time Period
      -
      Search
      Trading Date Shareholders Designation Shares Held Trading Day Shares Held Prev Trading Day Change
      2024-06-23 محمد سلطان حماد السبيعي Chairman 17.5000000% 17.5000000% 0
      2024-06-23 سامي عبدالكريم عبدالله العبدالكريم Board of Directors 0.0252220% 0.0252220% 0
      2024-06-23 محمد سليمان محمد السليم Board of Directors 0.0047600% 0.0047600% 0
      2024-06-23 ناصر سلطان فهد العريني السبيعي Senior Executives 17.5000000% 17.5000000% 0
      2024-06-23 محمد حمد راشد الكثيري Board of Directors 0.0002700% 0.0002700% 0
      2024-06-23 ناصر سلطان فهد العريني السبيعي Board of Directors 17.5000000% 17.5000000% 0
      2024-06-23 خالد سليمان محمد السليم Board of Directors 0.0047600% 0.0047600% 0
      • The listed company (Publisher) shall be responsible for the accuracy of the published information pertaining to the ownership of the Board of Directors, Chief Executive Officer or highest executive position, and the Chief Financial Officer. The listed company shall also be responsible for updating these information thereof. Therefore, the Saudi Stock Exchange (Tadawul) shall not be liable for the information contained therein, nor for any consequences that may result from the said information.
      for
      subs
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Peer Comparison

      • Table
      • Graphical
      Add Company

      Compare Selected

      Select a Maximum of 5 Companies

      Company Apply
      Mouwasat Medical Services Co.
      Price 124.80
      Market Cap (SAR MN) 24,480
      P/E Ratio 37.14
      Index Name Index Level 1D Return
      Mouwasat Medical Services Co. %
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Company Profile

      Company overview

      The Companys main activities are operating hospitals and dispensaries, which are either owned, rented or for a percentage of revenues as per the signed contracts

      Company History

      The origin of Mouwasat dates back to 1974 when an establishment solely owned by Mr. Mohammad Sultan Al-Subaie was established with a share capital of 100,000 SAR for the management and operation of medical facilities and started with the launching of Mouwasat Dispensary in Dammam in 1975. The Company established its first owned comprehensive medical facility in 1984 known as Mouwasat Hospital in Dammam, which commenced operation in 1988

      Company Bylaws

      Click here

      Equity Profile

      • Authorized Capital (SAR) 2,000,000,000
      • Issued Shares 200,000,000
      • Paid Capital (SAR) 2,000,000,000
      • Par Value/Share 10
      • Paid Up Value/Share 10

      Last Update :2023-08-08

      Investment limits

      There are no investment limits on the company shares as per the amended Rules for Qualified Foreign Financial Institutions Investment in Listed Securities and Instructions for the Foreign Strategic Investors Ownership in Listed Companies based on company bylaw and the issued instructions by the related regulators and supervisory authorities.

       

      • Company Details
      • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
      • Date Established

        1974/02/21

      • Financial Year End

        31/12

      • Listing Date

        2009/09/02

      • External Auditors

        [KPMG Al Fozan & Partners]

      • ISIN CODE

        SA12C051UH11

      • Number of Employees

        4084

      • Chairman

        Mohammad Sultan Hammad Alsubaie
        Non - Executive

        Mohammad Sultan Hammad Alsubaie
        • BD Session Start
          2023-01-04
          Designation
          Chairman
        • BD Session End
          2026-01-03
          Classification
          Non - Executive
        • Qualification
          Secondary School Training Courses in Business Administration
      • Board of Directors

        Nassir Sultan Fahed Alsubaei Deputy Chairman - Executive

        Nassir Sultan Fahed Alsubaei
        • BD Session Start
          2023-01-04
          Designation
          Board of Directors
        • BD Session End
          2026-01-03
          Classification
          Deputy Chairman - Executive
        • Qualification
          Healthcare Services Management Diploma - California USA Training Courses- Healthcare Services Management - Inside and Outside KSA

        Mohamed Soliman Mohammed Alsaleem Executive

        Mohamed Soliman Mohammed Alsaleem
        • BD Session Start
          2023-01-04
          Designation
          Board of Directors
        • BD Session End
          2026-01-03
          Classification
          Executive
        • Qualification
          Bachelor of Management Sciences - Accounting - King Saud University - Riyadh

        Khalid Suliman Mohammed Alsaleem Executive

        Khalid Suliman Mohammed Alsaleem
        • BD Session Start
          2023-01-04
          Designation
          Board of Directors
        • BD Session End
          2026-01-03
          Classification
          Executive
        • Qualification
          Comprehensive High School - Business Administration - 1985 King Saud University - Public Administration 1985 - 1987 English Language Diploma - Rice University - Houston - USA

        Sami Abdulkarim Abdallah Al Abdulkarim Independent

        Sami Abdulkarim Abdallah Al Abdulkarim
        • BD Session Start
          2023-01-04
          Designation
          Board of Directors
        • BD Session End
          2026-01-03
          Classification
          Independent
        • Qualification
          Master Degree - Dental Implant - The International Dental Implant Association Fellowship of Implantation of teeth Dental Medicine and Surgery - American International Dental Implantation Association Fellowship - Maxillofacial Surgery American College of Maxillofacial Surgeons Bachelor of Dental Medicine and Surgery - University of Sind - Pakistan n

        Fahad Ayed Saleh Alaslami Independent

        Fahad Ayed Saleh Alaslami
        • BD Session Start
          2023-01-04
          Designation
          Board of Directors
        • BD Session End
          2026-01-03
          Classification
          Independent
        • Qualification
          BS Degree - Accounting - Imam University SOCPA Fellowship CMA Fellowship - Management Accounting - IMA - US Executive Diploma Islamic Finance - Open University of Malaysia CFA charter - Financial Analysis - Investment - CFA Institute - US Emerging CFO Program - Strategic Financial Leadership - Stanford University - GSB School - US Oxford Real Estate Program - Oxford University - SAID business School - UK International Directors Program - Corporate Governance - Board of Directors development - INSEAD - France COSO ERM Certificate - Risk Management - COSO Committee - US Stanford Business Leadership Series SBLS - Business Strategy and Leadership - Stanford University - GSB School - US INSEAD Corporate Governance Certificate IDP - INSEAD - France

        Mohammed Hamad Rashed Alkathiri Independent

        Mohammed Hamad Rashed Alkathiri
        • BD Session Start
          2023-01-04
          Designation
          Board of Directors
        • BD Session End
          2026-01-03
          Classification
          Independent
        • Qualification
          PhD - Business strategic mgt - Manchester Uni. MBA - Business - Ottawa Uni - Canada BA - Business - King Saud Uni Training - Strategy and Board roles - INSEAD - IMD - IoD - BDI
      • Senior Executives

        Nassir Sultan Fahed Alsubaei CEO

        Nassir Sultan Fahed Alsubaei
        • BD Session Start
          2006-01-04
          Designation
          Senior Executives
        • BD Session End
          -
          Classification
          CEO
        • Qualification
          Healthcare Services Management Diploma - California USA Training Courses- Healthcare Services Management - Inside and Outside KSA

        Yousef Ahmad Suleiman CFO

      Yousef Ahmad Suleiman
      • BD Session Start
        2017-01-04
        Designation
        Senior Executives
      • BD Session End
        -
        Classification
        CFO
      • Qualification
        Bachelor Of Accountancy

      Investor Relations

      Contact Name:

      Mostafa Hosni Mostafa

      Company Address:

      Destect 71 - King Fahad Road P.O.Box 282 Dammam31411

      Contact Details:

      Telephone: 0138200016
      Fax : -
      Email : shares@mouwasat.com

      Company Website:

      www.mouwasat.com


      Name Of Subsidiary Percentage Of Property Main Business Location Of Operation Country Of Operation
      Eastern Medical Services Co 51.00% Establishment, operation and administration of hospitals, clinics and private medical clinics Kingdom of Saudi Arabia - Qatif Kingdom of Saudi Arabia
      Add To Watchlist
      In your Watchlist
      Add To Watchlist

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.